Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556226762> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W2556226762 endingPage "3049" @default.
- W2556226762 startingPage "3049" @default.
- W2556226762 abstract "Abstract Background: The addition of rituximab to chemotherapy (R-CHOP) has been shown to improve response rates in mantle cell lymphoma (MCL), but prolongation of response duration or overall survival was not observed (Lenz et al., JCO 2005). In a similar randomized comparison of 90 patients, again the addition of rituximab to MCP showed a tendency towards higher CR rates, but no improvement of overall response rate, progression free, or overall survival (Herold et al., ICML-10, 2008). Methods: We present an update of a previously published trial randomly comparing efficacy and safety of R-CHOP to CHOP induction in previously untreated patients with advanced stage MCL. Results: Of the 123 evaluable patients, 63 patients were randomized to R-CHOP. Median age was 62 years, and risk profiles of the two treatment arms were comparable. Overall response rates were 92% vs. 75% for R-CHOP vs. CHOP (p = 0.0139) and complete remission rates 33% vs. 8% (p = 0.0008). After a median follow-up of 65 months, median time to treatment failure was prolonged from 14 months for CHOP to 28 months for R-CHOP (p = 0.0003). Similarly, median response duration was prolonged from 18 (CHOP) to 29 months (R-CHOP, p = 0.0052). So far, no significant improvement of overall survival has been observed with median not reached vs. 59 months and 5-years OS rates of 59% and 46% (p = 0.27) after R-CHOP and CHOP, respectively. Toxicity was not significantly higher for R-CHOP treated patients. Conclusions: After longer follow-up, superior remission rates, time to treatment failure, and response duration of combined immuno-chemotherapy were confirmed. However, in contrast to other lymphoma entities, improvement of overall survival has not yet been proven in MCL patients. Therefore new therapeutic options are urgently warranted to further improve the long term outcome in this otherwise dismal disease." @default.
- W2556226762 created "2016-11-30" @default.
- W2556226762 creator A5009186146 @default.
- W2556226762 creator A5033079310 @default.
- W2556226762 creator A5033935778 @default.
- W2556226762 creator A5045850647 @default.
- W2556226762 creator A5046049357 @default.
- W2556226762 creator A5046718799 @default.
- W2556226762 creator A5051276031 @default.
- W2556226762 creator A5054794845 @default.
- W2556226762 creator A5059188766 @default.
- W2556226762 creator A5063547268 @default.
- W2556226762 creator A5080742745 @default.
- W2556226762 creator A5083748711 @default.
- W2556226762 creator A5085255418 @default.
- W2556226762 creator A5090442302 @default.
- W2556226762 date "2008-11-16" @default.
- W2556226762 modified "2023-09-29" @default.
- W2556226762 title "The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial" @default.
- W2556226762 doi "https://doi.org/10.1182/blood.v112.11.3049.3049" @default.
- W2556226762 hasPublicationYear "2008" @default.
- W2556226762 type Work @default.
- W2556226762 sameAs 2556226762 @default.
- W2556226762 citedByCount "15" @default.
- W2556226762 countsByYear W25562267622012 @default.
- W2556226762 countsByYear W25562267622013 @default.
- W2556226762 countsByYear W25562267622014 @default.
- W2556226762 countsByYear W25562267622015 @default.
- W2556226762 countsByYear W25562267622021 @default.
- W2556226762 countsByYear W25562267622022 @default.
- W2556226762 crossrefType "journal-article" @default.
- W2556226762 hasAuthorship W2556226762A5009186146 @default.
- W2556226762 hasAuthorship W2556226762A5033079310 @default.
- W2556226762 hasAuthorship W2556226762A5033935778 @default.
- W2556226762 hasAuthorship W2556226762A5045850647 @default.
- W2556226762 hasAuthorship W2556226762A5046049357 @default.
- W2556226762 hasAuthorship W2556226762A5046718799 @default.
- W2556226762 hasAuthorship W2556226762A5051276031 @default.
- W2556226762 hasAuthorship W2556226762A5054794845 @default.
- W2556226762 hasAuthorship W2556226762A5059188766 @default.
- W2556226762 hasAuthorship W2556226762A5063547268 @default.
- W2556226762 hasAuthorship W2556226762A5080742745 @default.
- W2556226762 hasAuthorship W2556226762A5083748711 @default.
- W2556226762 hasAuthorship W2556226762A5085255418 @default.
- W2556226762 hasAuthorship W2556226762A5090442302 @default.
- W2556226762 hasConcept C126322002 @default.
- W2556226762 hasConcept C141071460 @default.
- W2556226762 hasConcept C2776694085 @default.
- W2556226762 hasConcept C2776755627 @default.
- W2556226762 hasConcept C2777525834 @default.
- W2556226762 hasConcept C2779338263 @default.
- W2556226762 hasConcept C2779429289 @default.
- W2556226762 hasConcept C2779725641 @default.
- W2556226762 hasConcept C2780653079 @default.
- W2556226762 hasConcept C71924100 @default.
- W2556226762 hasConcept C90924648 @default.
- W2556226762 hasConceptScore W2556226762C126322002 @default.
- W2556226762 hasConceptScore W2556226762C141071460 @default.
- W2556226762 hasConceptScore W2556226762C2776694085 @default.
- W2556226762 hasConceptScore W2556226762C2776755627 @default.
- W2556226762 hasConceptScore W2556226762C2777525834 @default.
- W2556226762 hasConceptScore W2556226762C2779338263 @default.
- W2556226762 hasConceptScore W2556226762C2779429289 @default.
- W2556226762 hasConceptScore W2556226762C2779725641 @default.
- W2556226762 hasConceptScore W2556226762C2780653079 @default.
- W2556226762 hasConceptScore W2556226762C71924100 @default.
- W2556226762 hasConceptScore W2556226762C90924648 @default.
- W2556226762 hasIssue "11" @default.
- W2556226762 hasLocation W25562267621 @default.
- W2556226762 hasOpenAccess W2556226762 @default.
- W2556226762 hasPrimaryLocation W25562267621 @default.
- W2556226762 hasRelatedWork W1970884884 @default.
- W2556226762 hasRelatedWork W1982626297 @default.
- W2556226762 hasRelatedWork W2021110476 @default.
- W2556226762 hasRelatedWork W2112679438 @default.
- W2556226762 hasRelatedWork W2127682234 @default.
- W2556226762 hasRelatedWork W2374533761 @default.
- W2556226762 hasRelatedWork W2420112818 @default.
- W2556226762 hasRelatedWork W2514024584 @default.
- W2556226762 hasRelatedWork W2526961449 @default.
- W2556226762 hasRelatedWork W4385663150 @default.
- W2556226762 hasVolume "112" @default.
- W2556226762 isParatext "false" @default.
- W2556226762 isRetracted "false" @default.
- W2556226762 magId "2556226762" @default.
- W2556226762 workType "article" @default.